@article{d2cfbf1e72404378a9360b50ab40cdef,
title = "CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer.",
keywords = "LOCALLY ADVANCED HEAD, SQUAMOUS-CELL CARCINOMA, CONCURRENT RADIOTHERAPY, DOCETAXEL, CISPLATIN, FLUOROURACIL, CHEMORADIOTHERAPY, 5-FLUOROURACIL, CETUXIMAB, TRIAL",
author = "Thomas Melchardt and Clemens Hufnagl and Teresa Magnes and Lukas Weiss and Georg Hutarew and Daniel Neureiter and Alexander Schlattau and Gerhard Moser and Alexander Gaggl and Wolfgang Tr{\"a}nkenschuh and Richard Greil and Alexander Egle",
note = "Melchardt, Hufnagl, Magnes, Weiss, Greil, Egle: Department of Internal Medicine III, Paracelsus Medical University Salzburg, M{\"u}llner-Hauptstrasse 48-5020, Salzburg, Austria; Hutarew, Neureiter, Tr{\"a}nkenschuh: Institute of Pathology, Paracelsus Medical University Salzburg, M{\"u}llner-Hauptstrasse 48-5020, Salzburg, Austria; Schlattau: Institute of Radiology, Paracelsus Medical University Salzburg, M{\"u}llner-Hauptstrasse 48-5020, Salzburg, Austria; Moser: Department of Otorhinolaryngology, Paracelsus Medical University Salzburg, M{\"u}llner-Hauptstrasse 48-5020, Salzburg, Austria; Gaggl: Department of Oral and Maxillofacial Surgery, Paracelsus Medical University Salzburg, M{\"u}llner-Hauptstrasse 48-5020, Salzburg, Austria",
year = "2015",
doi = "10.1186/s12885-015-1776-x",
language = "English",
volume = "15",
pages = "725",
journal = "BMC CANCER",
issn = "1471-2407",
publisher = " BioMed Central",
}